OPKO Health
OPK
$1.32
Share price
1.54%
Change (1 day)
-16.46%
Change (1 year)
Categories
OPKO Health (OPK) - Cash on Hand
Cash on Hand as of December 2023 : $95.88 M
According to OPKO Health
's latest financial reports the company has $95.88 M in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
OPKO Health - Cash on Hand chart (from 2001 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $95.88 M | -37.41% |
| 2022-12-31 | $0.15 B | 13.72% |
| 2021-12-31 | $0.13 B | 86.55% |
| 2020-12-31 | $72.21 M | -15.5% |
| 2019-12-31 | $85.45 M | -11.42% |
| 2018-12-31 | $96.47 M | 5.44% |
| 2017-12-31 | $91.49 M | -45.77% |
| 2016-12-31 | $0.16 B | -12.84% |
| 2015-12-31 | $0.19 B | 99.78% |
| 2014-12-31 | $96.9 M | -47.84% |
| 2013-12-31 | $0.18 B | 579.06% |
| 2012-12-31 | $27.36 M | -61.74% |
| 2011-12-31 | $71.51 M | 296.96% |
| 2010-12-31 | $18.01 M | -57.77% |
| 2009-12-31 | $42.65 M | 538.78% |
| 2008-12-31 | $6.67 M | -71.43% |
| 2007-12-31 | $23.37 M | 20049.14% |
| 2006-12-31 | $0.11 M | -98.7% |
| 2005-12-31 | $8.9 M | -9.71% |
| 2004-12-31 | $9.85 M | -2.7% |
| 2003-12-31 | $10.13 M | -37.43% |
| 2002-12-31 | $16.19 M | 7.98% |
| 2001-12-31 | $14.99 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $26.21 B | 27,244.31% | 🇺🇸 USA |
 Abbott Laboratories ABT | $7.27 B | 7,491.70% | 🇺🇸 USA |
 Regeneron Pharmaceuticals REGN | $10.51 B | 10,871.41% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $9.67 B | 9,985.42% | 🇺🇸 USA |
 LabCorp LH | $99.3 M | 3.57% | 🇺🇸 USA |
 Alnylam Pharmaceuticals
ALNY | $2.37 B | 2,373.15% | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | $3.22 B | 3,264.59% | 🇮🇱 Israel |
 Ardelyx ARDX | $0.18 B | 92.22% | 🇺🇸 USA |